Rex Fang & Innovation Equity Premium Income ETF vs Herbalife Nutrition Ltd — how do they compare? Rex Fang & Innovation Equity Premium Income ETF trades at $43.51 (market cap $746.48M), while Herbalife Nutrition Ltd trades at $13.03 (market cap $1.34B). The key difference: Herbalife Nutrition Ltd is the larger of the two by market cap, and Rex Fang & Innovation Equity Premium Income ETF is more actively traded (334,337 versus 1,589,457). Which is the better fit depends on your goals — on Pluang, investors hold Rex Fang & Innovation Equity Premium Income ETF for 56 Days and Herbalife Nutrition Ltd for 43 Days on average.
| FEPI | HLF | |
|---|---|---|
Market Cap | $746.48M | $1.34B |
Volume | 334,337 | 1,589,457 |
Sector | Income / Options Overlay | Consumer Staples |
52-Week High | $49.54 | $19.96 |
52-Week Low | $37.98 | $7.75 |
Typical Hold Time | 56 Days | 43 Days |
Enterprise Value | — | $3.18B |
Signals from Pluang's Aura AI — not financial advice
FEPI (REX FANG & Innovation Equity Premium Income ETF) trades at $43.51, down 0.18% with a bullish technical signal from moving averages. The ETF employs a covered call strategy on concentrated AI and mega-cap tech holdings, generating high weekly distributions averaging $0.20-0.21. Recent articles highlight its 25% trailing yield but note capped upside potential and underperformance versus peers in total return during tech rallies.
The outlook balances high income generation against significant risk from tech concentration and volatility dependence. While the covered call strategy funds substantial dividends, it limits capital appreciation during market upswings. Key risks include drawdown vulnerability if tech stocks decline and competitive pressure from higher-performing income alternatives. Analyst sentiment remains cautious due to the trade-off between yield and total return potential.
Herbalife (HLF) trades at $12.86, up 1.62% on the day, with a bullish technical signal and a consensus analyst price target of $19.00 implying significant upside. The company reported Q2 2026 EPS of $0.51, missing expectations, but reaffirmed full-year 2026 guidance. Financials show a net income margin of 3.16% for 2025, with a low P/E of 8.22 and P/S of 0.26, suggesting potential undervaluation. Recent news includes a $250 million share repurchase authorization and a planned CEO transition effective October 31, 2026.
The outlook for HLF is cautiously optimistic, with valuation metrics and analyst sentiment supporting a bullish case, but risks include recent earnings misses, high debt levels, and ongoing leadership changes. The stock presents a value opportunity if the company can execute on its growth and margin expansion plans while managing its leverage.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →